Other researchers have also found that pulmonary tissue damage could be alleviated by neutralizing HMGB1 with a specific antibody in rats [15], identifying HMGB1 as a therapeutic target for ALI. This evidence concerns the gene HMGB1 and acute respiratory distress syndrome.